Hi, what are you looking for?
After consultation with ASX, European Lithium Ltd (ASX: EUR, FRA:PF8, OTC: EULIF) (European Lithium or the Company) is now releasing the 1st drill results...
Stardust Power Inc. (NASDAQ: SDST) (‘Stardust Power’ or the ‘Company’), an American developer of battery-grade lithium products, today announced the pricing of its ‘reasonable...
US President Donald Trump addressed world leaders and business executives at the World Economic Forum (WEF) in Davos, Switzerland, calling for Saudi Arabia and...
The second quarter of 2024 saw copper prices surge on the London Metals Exchange (LME) on the back of supply bottlenecks and elevated demand,...
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that it has delivered another strong revenue quarter. During Q2 of...
Endeavour Mining (LSE:EDV,TSX:EDV,OTCQX:EDVMF) said on Monday (July 2) that it has completed the first gold pour at its Lafigué mine in Côte d’Ivoire ahead...
Following the recently completed placement to sophisticated and institutional shareholders, GTI Energy Ltd (GTI or Company) is pleased to provide an update on the...
(TheNewswire) Toronto, Ontario TheNewswire – July 2, 2024 Noble Mineral Exploration Inc. ( ‘Noble’ or the ‘Company’ ) (TSX-V:NOB, FRANKFURT: NB7, OTCQB:NLPXF) is pleased...
North Arrow Minerals Inc. (TSXV: NAR) (‘ North Arrow’) is pleased to announce it has entered into an asset purchase agreement with Agnico Eagle...
When asked about the most important drivers for silver right now, he pointed to the solar industry, noting that two to three years ago...
(TheNewswire) Toronto, Ontario TheNewswire – July 2, 2024 Noble Mineral Exploration Inc. ( ‘Noble’ or the ‘Company’ ) (TSX-V:NOB, FRANKFURT: NB7, OTCQB:NLPXF) is pleased...
Tryptamine Therapeutics Limited (‘Tryp’ or the ‘Company’) (ASX: TYP), a clinical-stage biotechnology company focused on the development of an innovative and scalable intravenous-infused psilocin...
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...